|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-9-23
|
|
pubmed:abstractText |
This study assessed the activity of the mAb cetuximab in combination with cisplatin and 5-fluorouracil (5-FU) in advanced esophageal squamous cell carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
pubmed-author:Al-BatranS-ESE,
pubmed-author:ArnoldDD,
pubmed-author:GrabowskiPP,
pubmed-author:GretenTT,
pubmed-author:HofheinzRR,
pubmed-author:LangerRR,
pubmed-author:LordickFF,
pubmed-author:LorenzenSS,
pubmed-author:MüllerLL,
pubmed-author:MoehlerMM,
pubmed-author:PeschelCC,
pubmed-author:PorschenRR,
pubmed-author:RöthlingNN,
pubmed-author:SchusterTT,
pubmed-author:Thuss-PatiencePP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1667-73
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19549707-Adult,
pubmed-meshheading:19549707-Aged,
pubmed-meshheading:19549707-Antibodies, Monoclonal,
pubmed-meshheading:19549707-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19549707-Carcinoma, Squamous Cell,
pubmed-meshheading:19549707-Cisplatin,
pubmed-meshheading:19549707-Combined Modality Therapy,
pubmed-meshheading:19549707-Cross-Over Studies,
pubmed-meshheading:19549707-Diarrhea,
pubmed-meshheading:19549707-Disease-Free Survival,
pubmed-meshheading:19549707-Dose-Response Relationship, Drug,
pubmed-meshheading:19549707-Esophageal Neoplasms,
pubmed-meshheading:19549707-Female,
pubmed-meshheading:19549707-Fluorouracil,
pubmed-meshheading:19549707-Follow-Up Studies,
pubmed-meshheading:19549707-Humans,
pubmed-meshheading:19549707-Kaplan-Meier Estimate,
pubmed-meshheading:19549707-Male,
pubmed-meshheading:19549707-Middle Aged,
pubmed-meshheading:19549707-Nausea,
pubmed-meshheading:19549707-Neutropenia,
pubmed-meshheading:19549707-Survival Analysis,
pubmed-meshheading:19549707-Time Factors,
pubmed-meshheading:19549707-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie.
|
|
pubmed:affiliation |
Third Department of Internal Medicine (Hematology/Medical Oncology), Technical University of Munich, Munich. florian.lordick@med.uni-heidelberg.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
